{
    "ticker": "ENZL",
    "name": "Enzo Biochem, Inc.",
    "description": "Enzo Biochem, Inc. is a biotechnology company that focuses on the development of innovative diagnostic and therapeutic solutions. Established in 1976 and headquartered in New York, Enzo operates with a mission to improve patient care through advanced molecular diagnostics and research. The company is recognized for its proprietary technologies in the fields of molecular biology, genomics, and biochemistry. Enzo's core offerings include a range of laboratory services, proprietary reagents, and diagnostic tests that serve the needs of clinical laboratories, hospitals, and healthcare providers. They are particularly known for their work in oncology, infectious diseases, and genetic testing. Enzo has made significant contributions to the advancement of healthcare through its commitment to research and development, providing high-quality, cost-effective solutions for the medical community. With a focus on personalized medicine, Enzo aims to empower healthcare providers with the tools necessary to make informed decisions and improve patient outcomes. The company continues to expand its portfolio of products and services to meet the evolving demands of the healthcare industry, while maintaining a strong emphasis on innovation and quality.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "New York, USA",
    "founded": "1976",
    "website": "https://www.enzo.com",
    "ceo": "Elazar Rabbani",
    "social_media": {
        "twitter": "https://twitter.com/enzobiochem",
        "linkedin": "https://www.linkedin.com/company/enzo-biochem/"
    },
    "investor_relations": "https://www.enzo.com/investor-relations",
    "key_executives": [
        {
            "name": "Elazar Rabbani",
            "position": "CEO"
        },
        {
            "name": "Hamid A. Sadeghi",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Molecular Diagnostics",
            "products": [
                "Cancer Diagnostics",
                "Infectious Disease Testing",
                "Genetic Testing"
            ]
        },
        {
            "category": "Research Products",
            "products": [
                "Proprietary Reagents",
                "Laboratory Services"
            ]
        }
    ],
    "seo": {
        "meta_title": "Enzo Biochem, Inc. | Innovating Diagnostics and Therapeutics",
        "meta_description": "Explore Enzo Biochem, Inc., a leader in biotechnology focusing on innovative diagnostics and therapeutic solutions. Learn about their commitment to improving patient care through advanced technologies.",
        "keywords": [
            "Enzo Biochem",
            "Biotechnology",
            "Molecular Diagnostics",
            "Genetic Testing",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What does Enzo Biochem specialize in?",
            "answer": "Enzo Biochem specializes in molecular diagnostics and therapeutic solutions, focusing on oncology, infectious diseases, and genetic testing."
        },
        {
            "question": "Who is the CEO of Enzo Biochem?",
            "answer": "Elazar Rabbani is the CEO of Enzo Biochem, Inc."
        },
        {
            "question": "Where is Enzo Biochem headquartered?",
            "answer": "Enzo Biochem is headquartered in New York, USA."
        },
        {
            "question": "What are Enzo's main products?",
            "answer": "Enzo's main products include cancer diagnostics, infectious disease testing, and various proprietary reagents."
        },
        {
            "question": "When was Enzo Biochem founded?",
            "answer": "Enzo Biochem was founded in 1976."
        }
    ],
    "competitors": [
        "ILMN",
        "DGX",
        "LH"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "BMY"
    ]
}